Deerfield Management Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 53
Professionals
  • Investments
  • 239
  • Portfolio
  • 86
  • Exits
  • 138
Exits

Deerfield Management General Information

Description

Founded in 1994, Deerfield Management is an investment firm based in New York, New York. The firm seeks to invest in the healthcare, pharmaceutical, biotechnology, healthcare devices, supplies, healthcare services, life sciences, oncology and gaming sectors.

Contact Information

Year Founded
1994
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Hedge Fund
Primary Office
  • 780 Third Avenue
  • 37th floor
  • New York, NY 10017
  • United States
+1 (212) 000-0000

Deerfield Management Investments (239)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Bridge Medicines 12-Nov-2020 Early Stage VC 0000 Drug Discovery Generating Revenue 0000000 00000000
0000000000 00000 0 10-Nov-2020 00000 00000 000.00 Clinics/Outpatient Services Generating Revenue 000000 000000 00
0000000 0000000000 21-Oct-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 000000 0000000000 00
00000000 000 21-Oct-2020 0000 00000 Drug Discovery Pre-Clinical Trials
00000 00000000 13-Oct-2020 00000 00000 000.00 Biotechnology Clinical Trials - Phase 1
0-0000 22-Sep-2020 00000 00000 0000 Therapeutic Devices Clinical Trials - General 000000 0000000000 00
00000 (0000000 000 09-Sep-2020 00000 00000 0000 Managed Care Generating Revenue 000000 000000 00
00000000 000000 14-Aug-2020 00000 00000 Medical Records Systems Generating Revenue 0000 00000000
Reprieve Cardiovascular 04-Aug-2020 Early Stage VC 0000 Diagnostic Equipment Clinical Trials - General 000000 0000000000 00
Sema4 28-Jul-2020 Later Stage VC 00000 Laboratory Services (Healthcare) Generating Revenue 000000 0000000000 00
You’re viewing 10 of 239 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Deerfield Management Exits (138)

Company Name Exit Date Exit Type Exit Size
Olema Oncology 19-Nov-2020 IPO 00000
00000000 18-Nov-2020 0000000 000000
00000 000000000 08-Oct-2020 000 0000
0000000 02-Oct-2020 000 0000
0000000 000000 25-Sep-2020 000 0000
0000000 21-Sep-2020 0000000000
000000000 16-Sep-2020 000 0000
000000 0000000 06-Aug-2020 000 00000
Annexon Biosciences 24-Jul-2020 IPO 00000
Nkarta Therapeutics 13-Jul-2020 IPO 00000
You’re viewing 10 of 138 exits. Get the full list »

Deerfield Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Deerfield Management Team (72)

Name Title Deals Funds Boards Office
Jonathan Isler Chief Financial Officer & Partner New York, NY
Jana Jensen Ph.D Chief Operating Officer, Deerfield Discovery and Development New York, NY
Angelo Stornello Chief Technology Officer New York, NY
Alexander Karnal Partner & Managing Director 0 0 New York, NY
Alexis Cazé Partner & Managing Director New York, NY
You’re viewing 5 of 72 team members. Get the full list »

Deerfield Management Co-Investors (315)

Name With Exits Lead Partner Series Industry
OrbiMed 9 0 00 Series chart Industry bar
GV 0 0 Series chart Industry bar
New Enterprise Associates 0 0 Series chart Industry bar
RA Capital Management 0 0 0 Series chart Industry bar
The Invus Group 0 0 0 Series chart Industry bar
You’re viewing 5 of 315 co-investors. Get the full list »